Uncategorized

Uncategorized

Innovative Biofuel from Sugarcane: Revolutionizing Renewable Energy in India

A young innovator from Maharashtra has made headlines after developing a sustainable biofuel derived from sugarcane juice. Kanak Talware, a final-year student of chemical engineering at Jawaharlal Nehru Engineering College, part of MGM University, has been granted a patent by the Indian government for her unique process that converts sugarcane into clean-burning bioethanol. The innovation […]

Uncategorized

Harley-Davidson X350 Patent Revealed in India

In an exciting development for motorcycle enthusiasts, the patent for the Harley-Davidson X350 has surfaced in India, sparking widespread speculation about the potential launch of the entry-level roadster in the domestic market. Developed in collaboration with Chinese partner Qianjiang Motor, the X350 is Harley-Davidson’s strategic attempt to expand its footprint in the small-displacement motorcycle segment

Uncategorized

OmniActive Sues Bio‑Gen for Patent Infringement Over Eye Health Ingredients

OmniActive Health Technologies, a leading global supplier of clinically studied health and wellness ingredients, has filed a patent infringement lawsuit against Indian nutraceutical firm Bio‑Gen Extracts Pvt. Ltd. in the U.S. District Court for the Eastern District of Texas. The lawsuit centers on U.S. Patent No. 10,532,035, owned by OmniActive, which protects a proprietary formulation

Uncategorized

India Limits TB Drug Sales to Government Health Systems

The Drugs Controller General of India (DCGI) has limited the sale of key TB drugs—bedaquiline, delamanid, pretomanid, and rifapentine—exclusively to government healthcare systems under the NTEP to combat rising drug-resistant TB cases. In a significant move to curb the growing threat of drug-resistant tuberculosis (TB), the Drugs Controller General of India (DCGI) has issued a

Uncategorized

Dr. Reddy’s Challenges Novo Nordisk’s Ozempic Patent in India, Paving Way for Cheaper Weight Loss Drugs

Indian pharmaceutical major Dr. Reddy’s Laboratories has mounted a significant legal challenge against Novo Nordisk’s patent for semaglutide, the key ingredient in its blockbuster weight-loss and diabetes drug Ozempic, potentially opening the door for affordable generics in India and other emerging markets. Filed in the Delhi High Court, the challenge targets Novo’s secondary patent on

Uncategorized

Delhi High Court Stops Use of Deceptive “Domino’s” Variants in Trademark Dispute – Interim Relief for Domino’s Pizza

The Delhi High Court has granted interim relief to Domino’s IP Holder LLC and Jubilant FoodWorks Limited, restraining several businesses from using deceptively similar names to the globally recognized “Domino’s” trademark. The court passed the order in response to a trademark infringement lawsuit filed by Domino’s against fifteen different entities operating under names such as

Scroll to Top